GENE Market Cap History Table | ||||||
Also see: GENE Shares Outstanding History and GENE YTD Return |
GENE Market Cap History Table | ||||||
Also see: GENE Shares Outstanding History and GENE YTD Return |
GENE Market Cap History Chart | ||||||
-53.50% CAGR ![]() Mouse over chart for data details
|
GENE Stock Price Chart |
About Genetic Technologies Ltd. |
Genetic Technologies is a molecular diagnostics company that provides predictive testing and assessment tools to help physicians manage women's health. Co.'s key product, BREVAGenplus, was a clinically validated risk assessment test for non-hereditary breast cancer. Co. has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. Co. has developed two new cancer risk assessment tests branded as GeneType for Colorectal Cancer and GeneType for Breast Cancer. Co. also develops other risk assessment tests across a range of diseases, including cardiovascular disease, type 2 diabetes, prostate cancer and melanoma. We show 2 historical shares outstanding datapoints in our GENE shares outstanding history coverage, used to compute GENE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing GENE market cap history over the course of time is important for investors interested in comparing GENE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of GENE versus a peer is one thing; comparing GENE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like GENE can fluctuate over the course of history. With this page we aim to empower investors researching GENE by allowing them to research the GENE market cap history. |
GENE Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: The Importance of Market Cap | |
|
GENE Share Performance |
Market Cap Peers |
Genetic Technologies. (GENE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
GERN Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.